EMAIL THIS PAGE TO A FRIEND

Atherosclerosis

CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism.


PMID 24950000

Abstract

We're sorry this abstract is currently not available.